AT
AV Therapeutics, Inc. Stock: price and insider trades · United States
AV Therapeutics, Inc.: what insiders have been doing
AV Therapeutics, Inc. has a thin disclosure history in our data (latest filing: 21 January 2015). New filings will appear here as soon as they are published. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 21 January 2015
Declarations2 total
- 1,200,000 sharesCommon StockSEC:0001185185-15-000130:0
- 650,000 sharesCommon StockSEC:0001185185-14-001811:0
2 of 2 declarations
About AV Therapeutics, Inc.
AV Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for disease treatment. It is listed on NASDAQ under the symbol AVTX.
